» Articles » PMID: 37725372

Lysosomal Cholesterol Overload in Macrophages Promotes Liver Fibrosis in a Mouse Model of NASH

Abstract

Accumulation of lipotoxic lipids, such as free cholesterol, induces hepatocyte death and subsequent inflammation and fibrosis in the pathogenesis of nonalcoholic steatohepatitis (NASH). However, the underlying mechanisms remain unclear. We have previously reported that hepatocyte death locally induces phenotypic changes in the macrophages surrounding the corpse and remnant lipids, thereby promoting liver fibrosis in a murine model of NASH. Here, we demonstrated that lysosomal cholesterol overload triggers lysosomal dysfunction and profibrotic activation of macrophages during the development of NASH. β-cyclodextrin polyrotaxane (βCD-PRX), a unique supramolecule, is designed to elicit free cholesterol from lysosomes. Treatment with βCD-PRX ameliorated cholesterol accumulation and profibrotic activation of macrophages surrounding dead hepatocytes with cholesterol crystals, thereby suppressing liver fibrosis in a NASH model, without affecting the hepatic cholesterol levels. In vitro experiments revealed that cholesterol-induced lysosomal stress triggered profibrotic activation in macrophages predisposed to the steatotic microenvironment. This study provides evidence that dysregulated cholesterol metabolism in macrophages would be a novel mechanism of NASH.

Citing Articles

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.

Devasia A, Ramasamy A, Leo C Int J Mol Sci. 2025; 26(4).

PMID: 40004240 PMC: 11855529. DOI: 10.3390/ijms26041778.


Caveolin-1 mitigates the advancement of metabolic dysfunction-associated steatotic liver disease by reducing endoplasmic reticulum stress and pyroptosis through the restoration of cholesterol homeostasis.

Xu H, Li Y, Guo N, Wu S, Liu C, Gui Z Int J Biol Sci. 2025; 21(2):490-506.

PMID: 39781461 PMC: 11705642. DOI: 10.7150/ijbs.100794.


Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model.

Yakubo S, Abe H, Li Y, Kudo M, Kimura A, Wakabayashi T Diseases. 2024; 12(12.

PMID: 39727647 PMC: 11727104. DOI: 10.3390/diseases12120317.


Cholesterol crystals in the pathogenesis of atherosclerosis.

Baumer Y, Irei J, Boisvert W Nat Rev Cardiol. 2024; .

PMID: 39558130 DOI: 10.1038/s41569-024-01100-3.


Myeloid-derived β-hexosaminidase is essential for neuronal health and lysosome function: implications for Sandhoff disease.

Tsourmas K, Butler C, Kwang N, Sloane Z, Dykman K, Maloof G bioRxiv. 2024; .

PMID: 39484433 PMC: 11526954. DOI: 10.1101/2024.10.21.619538.


References
1.
Kanamori Y, Tanaka M, Itoh M, Ochi K, Ito A, Hidaka I . Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH. iScience. 2021; 24(2):102032. PMC: 7820131. DOI: 10.1016/j.isci.2020.102032. View

2.
Savard C, Tartaglione E, Kuver R, Haigh W, Farrell G, Subramanian S . Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology. 2012; 57(1):81-92. PMC: 5341743. DOI: 10.1002/hep.25789. View

3.
Liu B, Turley S, Burns D, Miller A, Repa J, Dietschy J . Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc Natl Acad Sci U S A. 2009; 106(7):2377-82. PMC: 2650164. DOI: 10.1073/pnas.0810895106. View

4.
Sano J, Shirakura S, Oda S, Hara T, Ishihara T . Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats. Pathol Int. 2004; 54(12):904-13. DOI: 10.1111/j.1440-1827.2004.01778.x. View

5.
Pertea M, Pertea G, Antonescu C, Chang T, Mendell J, Salzberg S . StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015; 33(3):290-5. PMC: 4643835. DOI: 10.1038/nbt.3122. View